Iontophoretic skin delivery systems: Success and failures

被引:78
作者
Bakshi, P. [1 ]
Vora, D. [1 ]
Hemmady, K. [2 ]
Banga, A. K. [1 ]
机构
[1] Mercer Univ, Coll Pharm, Dept Pharmaceut Sci, Ctr Drug Delivery Res, Atlanta, GA 30341 USA
[2] Frimley Pk Hosp NHS Fdn Trust, Frimley, Surrey, England
关键词
Iontophoresis; Macromolecules; Hydrophilic molecules; Controlled drug delivery; Iontophoretic patches; TRANSDERMAL DELIVERY; DRUG-DELIVERY; PENETRATION ENHANCER; CHEMICAL ENHANCERS; TRANSPORT; DEVICES; SUMATRIPTAN; PEPTIDE; PROTEIN; FORMULATION;
D O I
10.1016/j.ijpharm.2020.119584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Iontophoretic transdermal delivery uses a small electric current to push charged molecules into the skin under an electrode of same polarity and offers an attractive option to facilitate the delivery of macromolecules or hydrophilic molecules and to improve patient compliance. This technique has been used in physical therapy clinics for several decades, though the science was not always there to support claims of clinical effectiveness. Recently, this modality of treatment has undergone more systematic and rigorous investigations to withstand the scrutiny of regulatory authorities. In recent years various drugs have gained FDA approval for iontophoretic patches. This technique is gaining recognition due to better compliance rates, non-invasive drug delivery leading to fewer side effects, and sustained release of the drug. Furthermore, programmed delivery and bolus delivery systems have helped with customizing the drug dosage and frequency of dosage based on the patient's need.
引用
收藏
页数:9
相关论文
共 86 条
[1]   Where do triptans act in the treatment of migraine? [J].
Ahn, AH ;
Basbaum, AI .
PAIN, 2005, 115 (1-2) :1-4
[2]  
[Anonymous], 2015, MED CO ANN FDA APPR
[3]  
[Anonymous], 2016, FDA EV RISK BURNS SC
[4]   Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged [J].
Apfelbaum, JL ;
Chen, C ;
Mehta, SS ;
Gan, TJ .
ANESTHESIA AND ANALGESIA, 2003, 97 (02) :534-540
[5]   HYDROGEL-BASED IONTOTHERAPEUTIC DELIVERY DEVICES FOR TRANSDERMAL DELIVERY OF PEPTIDE PROTEIN DRUGS [J].
BANGA, AK ;
CHIEN, YW .
PHARMACEUTICAL RESEARCH, 1993, 10 (05) :697-702
[6]  
Banga AK, 2011, TRANSDERMAL AND INTRADERMAL DELIVERY OF THERAPEUTIC AGENTS: APPLICATION OF PHYSICAL TECHNOLOGIES, P1, DOI 10.1201/b10906
[7]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[8]  
Bath BD, 2000, J PHARM SCI-US, V89, P1537, DOI 10.1002/1520-6017(200012)89:12<1537::AID-JPS4>3.0.CO
[9]  
2-J
[10]   Pharmacotherapy for Cluster Headache [J].
Brandt, Roemer B. ;
Doesborg, Patty G. G. ;
Haan, Joost ;
Ferrari, Michel D. ;
Fronczek, Rolf .
CNS DRUGS, 2020, 34 (02) :171-184